Leveraging Trans-Canada Expertise and Resources to Design and Evaluate Novel Auger Electron-Emitting Radioimmunotherapies (RIT) for Metastatic Triple-Negative Breast Cancer (TNBC)
Leveraging Trans-Canada Expertise and Resources to Design and Evaluate Novel Auger Electron-Emitting Radioimmunotherapies (RIT) for Metastatic Triple-Negative Breast Cancer (TNBC)
利用横贯加拿大的专业知识和资源来设计和评估用于转移性三阴性乳腺癌 (TNBC) 的新型俄歇电子发射放射免疫疗法 (RIT)
批准号：
444783
负责人：
Radchenko Valery
金额：
$40.96万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-04-01 至 2025-04-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project, a team of researchers from across Canada with unique and complementary expertise and resources will work together to develop and study new targeted radiation treatments for triple-negative breast cancer (TNBC), a form of the disease which
期刊论文(0)
专著(0)
科研奖励(0)
会议论文